NERATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where NERATINIB was used for Neoplasm malignant.
Most Reported Side Effects for NERATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,193 | 57.1% | 150 | 358 |
| Nausea | 527 | 25.2% | 56 | 150 |
| Fatigue | 446 | 21.4% | 71 | 118 |
| Off label use | 383 | 18.3% | 137 | 178 |
| Vomiting | 297 | 14.2% | 44 | 128 |
| Constipation | 267 | 12.8% | 23 | 67 |
| Decreased appetite | 245 | 11.7% | 62 | 93 |
| Death | 181 | 8.7% | 181 | 48 |
| Disease progression | 142 | 6.8% | 92 | 78 |
| Weight decreased | 132 | 6.3% | 55 | 55 |
| Dehydration | 129 | 6.2% | 12 | 75 |
| Abdominal pain | 114 | 5.5% | 19 | 29 |
| Headache | 110 | 5.3% | 6 | 38 |
| Dizziness | 96 | 4.6% | 6 | 32 |
| Abdominal pain upper | 95 | 4.6% | 6 | 26 |
Other Indications for NERATINIB
Breast cancer (714)
Breast cancer female (417)
Product used for unknown indication (280)
Her2 positive breast cancer (274)
Breast cancer metastatic (207)
Her-2 positive breast cancer (88)
Metastatic neoplasm (19)
Metastases to central nervous system (15)
Off label use (15)
Breast cancer stage iv (12)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)